Georgia Retina Welcomes Dr. Krishna Mukkamala

Retina Specialist to Practice at Georgia Retina Cumming and Northside Offices

August 5, 2013 (Atlanta) — Georgia Retina — the state’s largest retina-only private practice — continues to grow and expand its services with the addition of retina specialist Dr. Krishna Mukkamala.

Dr. Mukkamala is currently seeing patients at the Georgia Retina Cumming office (960 Sanders Road, Suite 500; 678-679-4830) and Northside office (1100 Johnson Ferry Road NE, Building 2, Suite 593; 404-255-9096).

Paul Lucas, Georgia Retina CFO, said, “We are excited to have such an experienced doctor join Georgia Retina. Dr. Mukkamala’s presence at our Cumming and Northside offices will certainly add to our status as Georgia’s leading retina-only private practice.”

Dr. Mukkamala said, “ Georgia Retina’s reputation is one of excellence, and I am very proud to be joining such a recognized practice in Georgia.”

Dr. Mukkamala received his medical degree at the Medical College of Virginia/VCU School of Medicine. He then completed an ophthalmology residency at the New York Eye and Ear Infirmary. Following residency, Dr. Mukkamala completed a retina fellowship at Columbia University College of Physicians and Surgeons and Vitreous Retina Macula Consultants of New York.

Dr. Mukkamala has been involved in many clinical trials and has published several articles in highly regarded ophthalmology journals such as Retina, Survey of Ophthalmology, and Archives of Ophthalmology. Additionally, Dr. Mukkamala has written a textbook chapter on Age-Related Macular Degeneration (AMD). He has trained with international leaders in both surgical and medical care of retinal diseases.

At Georgia Retina, patients’ vision needs are the top priority. As one of the largest retina-only medical practices in the southeastern United States, Georgia Retina specializes in treating diseases of the retina, macula, and vitreous. Its eleven board-certified ophthalmologists have received special Fellowship training in vitreo-retinal diseases and surgery, and are engaged in clinical trials with the goal of advancing research into retinal diseases, their causes, and their cures. For more information, visit www.garetina.com.